Contacts Investors: [email protected] 619-393-1545 Media: Tracy Morris VP of Global Corporate Communications [email protected] 650-380-4413 ...

Contacts Investors: Shayla Gorman [email protected] 619-393-1545 Media: Tracy Morris [email protected] 650-380-4413 ...

Veracyte, Inc., a leading cancer diagnostics company, today announced that three Afirma-related abstracts will be presented at ENDO 2025, the annual meeting of the Endocrine Society, taking place ...

Veracyte price target lowered to $30 from $35 at Needham Veracyte raises FY23 revenue view to $352M-$354M from $342M-$350M Veracyte reports Q3 EPS (41c), consensus (15c) ...